NCT00446459View on ClinicalTrials.gov

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGAHypertension, Renal
Interventions
DRUG

mycophenolate mofetil (CellCept)

500mg - 1,000mg, taken PO, twice daily.

Trial Locations (1)

98195

Universtiy of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

University of Washington

OTHER

NCT00446459 - Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. | Biotech Hunter | Biotech Hunter